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The involvement of mitochondrial uncoupling proteins 2 and 3 in the pathogenesis of
cardiovascular diseases is widely acknowledged. However, contradictory reports show
that the functions of UCP2/UCP3 are still disputed. We have previously described that
UCP2 is highly abundant in cells that rely on glycolysis, such as stem, cancer and
activated immune cells. In contrast, high amounts of UCP3 are present in brown adipose
tissue, followed by heart and skeletal muscles - all known to metabolize fatty acids (FA)
to a high extent. Using two different models – mouse embryonic stem cell (mESC)
differentiation to cardiomyocytes (CM) and murine heart at different developmental
stages – we now tested the concept that the expression ratio between UCP2 and UCP3
indicates the metabolism type in CM. Our results revealed the tight correlation between
UCP3 abundance, expression of mitochondrial fatty acid oxidation (FAO) markers and
presence of multiple connections between mitochondria and lipid droplets. We further
demonstrated that the time course of UCP3 expression neither coincided with the
onset of the electrical activity in CM, derived from mESC, nor with the expression of
respiratory chain proteins, the observation which rendered protein participation in ROS
regulation unlikely. The present data imply that UCP3 may facilitate FAO by transporting
FAs into mitochondria. In contrast, UCP2 was highly abundant at early stages of heart
development and in mESC. Understanding, that the expression patterns of UCP3 and
UCP2 in heart during development reflect the type of the cell metabolism is key to
the uncovering their different functions. Their expression ratio may be an important
diagnostic criterion for the degree of CM differentiation and/or severity of a heart failure.
Keywords: respiratory chain proteins, oxygen consumption rate (OCR), mitochondrial morphology, lipid droplets,
cell metabolism, mESC-derived cardiomyocytes
Abbreviations: CI, complex I; CII, succinate dehydrogenase complex subunit A; CM, cardiomyocytes; CV, ATP-Synthase,
β–subunit; d14, day 14 of differentiation; E18, embryo day 18; EB, embryo bodies; ECAR, extracellular acidification rate;
FA, fatty acids; FAO, fatty acid oxidation; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; He, heart; Li, liver; mESC,
mouse embryonic stem cells; mLIF, murine leukaemia inhibitory factor; mUCP3, mouse recombinant UCP3; OCR, oxygen
consumption rate; P1, postnatal day 1; RC, respiratory chain; ROS, reactive oxygen species; Serca2, sarco/endoplasmic
reticulum calcium-ATPase 2; SkM, skeletal muscle; Std, standard; TnC, Troponin C; TnI, Troponin I; TMRE, tetramethyl
rhodamine ethyl ester; UCP3, uncoupling protein 3; VDAC, voltage-dependent anion channel; WB, Western blot; wt, wild
type mouse.
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INTRODUCTION
One of cardiovascular disease’s important hallmarks is
mitochondrial dysfunction resulting in abnormal energy
metabolism and increased ROS production in CM (Madamanchi
and Runge, 2007). Members of the mitochondrial uncoupling
protein family, UCP2 and UCP3, are thought to be beneficial in
heart failure mainly by reducing ROS through mild uncoupling.
However, despite extensive research in many laboratories, the
function and even abundance of these two highly homologous
proteins at different stages of heart development and in heart
diseases remain elusive. Several studies failed to describe a clear
phenotype for both genetic models UCP2−/− and UCP3−/−,
mainly because they generally do not take into account that
diseases (especially metabolic) may have polygenic origins and/or
be affected by environmental factors (Harper and Himms-Hagen,
2001). It was reported that a decrease or loss of UCP3 in rodent
knockout models diminished the contractile heart function,
increased ROS production and tissue damage following ischemia
(Harmancey et al., 2013; Ozcan et al., 2013; Perrino et al., 2013),
whereas other research groups demonstrated that a lack of UCP3
led to a higher death rate in mice due to cardiac arrhythmias
upon lipid-challenged conditions (Nabben et al., 2014).
It is now becoming obvious that (i) no reasonable conclusions
can be made if only based on UCP2/UCP3 gene expression,
because both proteins have a strong translational regulation
and short life-time (Pecqueur et al., 2001; Rousset et al., 2007;
Rupprecht et al., 2012) and (ii) the expression of each uncoupling
protein is confined to definite tissues or cells. That is, we and
several other groups have previously demonstrated that UCP2,
which mRNA was found nearly ubiquitously (Fleury et al., 1997;
Alan et al., 2009), is present at protein level exclusively in highly
proliferating cells, which have a glycolytic type of metabolism,
such as cancer, stem and activated immune cells (Pecqueur et al.,
2001; Alves-Guerra et al., 2003; Zhang et al., 2011; Rupprecht
et al., 2012, 2014; Yu et al., 2013). In contrast, the expression
pattern of UCP3, which was only found in brown adipose tissue,
heart and SkMs, may imply a connection to another type of
metabolism – fatty acid β-oxidation (FAO) (Hilse et al., 2016) -
the hypothesis, which we have tested in the present study.
For this, we compared cell oxygen consumption, abundance
of UCP2/UCP3, key mitochondrial proteins (VDAC,
respiratory chain proteins), specific cardiomyocyte markers
(SERCA2, GATA4 and troponin), specific markers of FAO
and mitochondrial morphology during (1) murine (heart)
development and (2) stem cell differentiation (mESC) to CM.
The main advantage of these two models is that the behavior of
both proteins can be studied during physiological alteration of
the metabolic environment.
MATERIALS AND METHODS
Animals and Tissue Samples Preparation
Embryonal, postnatal and adult females of C57BL/6 wt mice were
used. The animals were kept in a 12:12 h light-dark cycle at
room temperature and had unlimited access to food and water.
Mice were sacrificed by decapitation or cervical dislocation in
accordance with the guidelines for animal care and approved by
the Ethical Committee of the University of Veterinary Medicine,
Vienna. Tissues were shock-frozen in liquid nitrogen or fixed
in 3% glutaraldehyde for electron microscopy immediately after
preparation. Murine hearts were homogenized in RIPA buffer
supplemented with a protease inhibitor cocktail using a mixer
mill (MM200, Retsch, Germany) and then sonicated (Hilse
et al., 2016). After 30 min of incubation on ice, the lysates
were centrifuged 2 × 10 min at 2500g. The supernatants were
collected, aliquoted and stored frozen at−80◦C. The total protein
concentration was determined with a Pierce BCA Protein Assay
Kit (Thermo Fischer Scientific).
Western Blot Analysis
Western blot analysis was performed as described previously
(Hilse et al., 2016). We used antibodies against UCP3 and
UCP2 [evaluated in (Hilse et al., 2016) and (Rupprecht et al.,
2012), respectively], CII (SDHA, succinate dehydrogenase
complex subunit A, Abcam ab14715, dilution 1:7500), GAPDH
(glyceraldehyde-3-phosphate-dehydrogenase, Sigma-Aldrich
G8795 dilution 1:7500), CI (NDUFA9, Invitrogen 459100,
dilution 1:3000), CV (ATP-Synthase, β–subunit, Invitrogen
A-2135, dilution 1:5000), α-actin (Abcam ab88226, dilution
1:3000), GATA4 (Santa Cruz sc-25310, dilution 1:1500), TnC
(Troponin T-C, Santa Cruz sc-20025, dilution 1:1500), TnI
(Troponin I, Santa Cruz sc-365446, dilution 1:1500), Serca1
(sarco-/endoplasmic reticulum calcium-ATPase 1, Santa Cruz sc-
515162, dilution 1:1500), Serca2 (sarco-/endoplasmic reticulum
calcium-ATPase 2, Abcam ab2861, dilution 1:7500), VDAC
(Abcam ab14734, dilution 1:5000) and Oct 3/4 (Santa Cruz
sc-9081; 1:1500). All antibodies were diluted in 2% BSA solution.
Detection was performed by luminescence reaction using a
secondary antibody against rabbit or mouse antibodies linked
with horseradish peroxidase (GE Healthcare, Austria) and ECL
Western Blotting reagent (Bio-Rad, Austria) using ChemiDoc-It
600 Imaging System (UVP, United Kingdom). The control
proteins were detected on membranes prior to be stripped with
a strip solution (100 mM sodium citrate at pH 2.2) for at least
1 min, washed and blocked for 30 min in block solution and
incubated again with next control antibody.
We employed the Launch Vision Works LS software (UVP,
United Kingdom) for quantification. The relative amount was
calculated as a ratio between the sample and loaded standard
(heart standard or mouse recombinant protein UCP2 (Hilse et al.,
2016), see figure description). The heart standard was prepared
from pooled hearts of 2–5 months old C57BL/6 wt mice (n = 15).
20 µg of the heart standard was loaded per lane.
Cardiomyocyte Differentiation
We differentiated mESC (clone D3-ATCC) to CM according
to the published protocol (Seiler and Spielmann, 2011).
Stem cells were cultured in DMEM medium (high glucose
with L-glutamine, without sodium pyruvate; Thermo Fisher
Scientific) supplemented with 15% fetal calf serum, 2 mM
glutamine, 1% non-essential amino acids, antibiotics (penicillin/
streptomycin solution 50 U/ml) and 0.1 mM β-Mercaptoethanol.
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The maintenance medium was supplemented with mLIF (murine
leukemia inhibitory factor, 106 U ml−1; Millipore), which was
added directly to the plate for maintaining pluripotency and
to avoid differentiation. Cells were passaged every 2–3 days.
Differentiation into CM was initiated after 2 days in culture as a
hanging drop after LIF omission. Formed EB were splashed into
petri dishes and cultured for the subsequent 2 days. Finally, EB
were transferred into 6-well plates and cultured for a maximum
of 28 days in humidified atmosphere under normoxic conditions
(5% CO2 and atmospheric oxygen 21% O2) at 37◦C with a change
in half the amount of medium every 3–4 days.
Confocal Microscopy
To visualize the mitochondria, mESC and mESC-derived CM (at
day 14) were incubated with 12.5 nM TMRE for 20 min and
measured with an inverse confocal laser scanning microscope
(Leica TCS SP5 II) as described in Zimmermann et al. (2017).
Cells were kept under the microscope in a heating box (37◦C)
supplied with 5% CO2. TMRE was excited with a DPPS laser at a
wavelength of 561 nm. Fluorescence was collected through a 40×
oil immersion objective in an emission channel of 570 – 690 nm
(512 × 512 pixels; scan speed 200 Hz). Images were recorded at
intervals of 133 ms (256 × 256 pixel; scan speed 1000 Hz) for
determination of the cell beat frequencies.
Electron Microscopy
Samples (cell cultures and mouse hearts) were fixed in 3%
buffered glutaraldehyde (pH 7.4, Merck, Darmstadt, Germany).
The cell culture pellets were pre-embedded in 1.5% agar and
washed with 0.1 M Sorensen phosphate buffer at pH 7.4.
All samples were subsequently fixed in 1% osmium tetroxide
(Electron Microscopy Sciences, Hatfield, United States) followed
by dehydration in a series of ethanol dilutions (70, 80, 96,
and 100%), embedded in epon-resin and polymerised 48 h at
60◦C. Semi-thin sections (0.8 µm) were stained with toluidine
blue, ultra-thin sections (70 nm) were mounted on copper grids
(Gröpl, Tulln, Austria) and stained with uranyl acetate and
lead citrate. Transmission electron micrographs were made with
EM900 (Zeiss, Oberkochen, Germany).
Determination of the Oxygen
Consumption Rate (OCR) and
Extracellular Acidification Rate (ECAR)
Mouse embryonic stem cell cells were seeded on gelatine-coated
Seahorse 96XFe plates (Agilent) at least 16 h before analysis with
an amount of 30,000 cells per well in the maintenance media
(80 µl/well). To analyze differentiated mESC at day 14 (d14), one
at d5 formed EB were seeded per well on gelatine-coated Seahorse
96XFe plates and grown for 9 days in maintenance media. Half of
the media was changed every 2–3 days.
For determination of the energetic profile, medium was
changed to 180 µl/well unbuffered XF base media (pH 7.4) an
hour prior to analysis. XF base media contained 20 mM glucose,
5 mM glutamine and 1xNEEA equivalent to the content of the
maintenance media. The cells were two times washed and then
incubated with the XF base media in a non-CO2 incubator.
Oxygen consumption rate and ECAR were determined in
parallel using the Seahorse XFe96 extracellular flux analyzer
(Agilent) according to standard protocol, but for a measuring
time of 2 min. After the experiment, cells were washed with
PBS and 20 µl RIPA per well was added. The plate was stored
at −20◦C before protein determination by Pierce BCA Protein
Assay Kit. Each experiment was performed on a new plate
using independent subcultures of mESC and differentiation
experiments. Only the inner 60 wells were taken into account.
OCR and ECAR were normalized to µg protein per well and
calculated as a mean with standard derivation from at least 14
technical replicates per energetic profile experiment.
RNA Isolation and Quantitative Real
Time PCR
Shock frozen hearts from E18, P1 and P7 and P30 were
homogenized in liquid nitrogen using a mixer mill (MM200,
Retsch, Germany). RNA from homogenized tissue and cells
(mESC, d10, d19) samples were extracted in TRI Reagent
(Invitrogen) according to manufacturer’s protocol. RNA
concentration was determined using NanoDropTM (Thermo
Fisher Scientific). One microgram of isolated RNA was used
for cDNA production with the “High Capacity cDNA reverse
Transcription kit” (Applied Biosystems). Quantitative real time
PCR was performed with the QuantiFast Multiplex PCR +R Kit
(Qiagen) and specific probes of TaqManTM Gene Expression
Assay for following genes: Slc27a6 – Mm01258609_m1, Cpt1b –
Mm00487191_g1, Acadvl – Mm00444293_m1, Ppargc1a -
Mm01208835_m1 ID 4453320 and GAPDH – Mm99999915_g1
ID 4448484. The qRT-PCR was run on StepOnePlus (Applied
Biosystem) and the software StepOne (Applied Biosystem) was
used for data analysis. Melting curve calculations were done
for all assays. Target genes were normalized to GAPDH as a
housekeeping gene.
Statistical Analysis
Data from WB analysis are presented as a mean ± SEM from at
least three independent experiments. Data were analyzed with a
t-test or one-way ANOVA by more than two groups. Data were
considered to be statistically significant at ∗p < 0.05, ∗∗p < 0.01
and ∗∗∗p < 0.001 The analysis was carried out using Sigma Plot
12.5 software.
RESULTS
Expression of Highly Homologous UCP3
and UCP2 in Heart Is Different During
Embryonic Stage and Development of
Mice
To address the conflicting reports about the presence of both
proteins - UCP2 and UCP3 - in heart we analyzed UCP2 and
UCP3 content at different time points of heart development: at
embryonic stage (E18), one and 7 days after birth (P1 and P7),
at two growth stages (P30 and P60) and in adult mice (P150
and P300) using antibodies that we have previously evaluated
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(Hilse et al., 2016). Figure 1A shows that UCP3 is not expressed
in embryonic heart (E18) and first appears after birth with an
expression peak at day 30, followed by a slight decline during
the aging process. In contrast, we detected UCP2 already in
embryonic heart, it has its expression peak in the 1st week
after birth and vanishes after 1 month at the latest (Figure 1B;
Supplementary Figure S1).
In the next step we evaluated whether UCP3 and UCP2
abundance correlated with the presence of proteins, which
serve as markers for differentiated adult CM. Figure 1C
shows that the expression of SERCA2 (Ca2+-ATPase type 2,
specifically localized in sarco/endoplasmic reticulum), GATA4
(transcription factor expressed during myocardial development
and growth) and TnC (subunit of the troponin complex, which is
FIGURE 1 | UCP3 and UCP2 expression during heart development. (A–E) Representative WBs and quantification for UCP3 (A) and UCP2 (B), cardiac proteins –
SERCA2, GATA4, Troponin C (C), respiratory chain proteins of the inner mitochondrial membrane Complex I, II, V (D), outer mitochondrial membrane protein VDAC,
and cardiac muscle marker α-actin (E) in mice during heart development. The relative protein amounts were calculated as a ratio between line intensity of sample to
standard (heart standard or mUCP2). 20 µg of total protein from tissue were loaded per lane. Recombinant mouse UCP3 (mUCP3, 5 ng) and mUCP2 (2.5 ng) were
used as positive controls. GAPDH was used as a loading control. At least 5 samples of pooled embryos (E18) or postnatal day 1-300 (P1-P300) heart tissue were
analyzed. Data are presented as mean values ± SEM, ∗∗p < 0.01 and ∗∗∗p < 0.001.
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responsible for muscle contraction) started at E18 and achieved
its maximum between 30 and 60 days, largely coinciding with
the expression pattern of UCP3 (Figure 1A). To evaluate
whether there is a putative connection between UCP3 and the
mitochondrial RC function, we measured the abundance of CI,
CII, and ATP synthase (CV) at different developmental stages.
Figure 1D demonstrates that CI and CII are already present in
embryonic heart in high amounts. All three proteins achieved
the expression maximum at P60. Whereas CI and CV declined
slightly with aging, CII abundance increased steadily up to 10
months after birth. In contrast, the expression of the VDAC,
known to transport metabolites through the outer mitochondrial
membrane (Colombini, 1979; Noskov et al., 2016), was nearly
constant in embryonic heart and over the first 5 months of mouse
life (Figure 1E). Notably, α-actin – a commonly used structural
marker for skeletal and heart muscles – was highly abundant
at E18 and showed a continuous reduction in amount with an
increase in age (Figure 1E).
UCP3 Is Not Involved in Electrical
Activity and Contractility of
Cardiomyocytes
To correlate UCP3 expression with the degree of cell maturity,
we differentiated murine embryonic stem cells (mESC) to CM
according to the protocol described previously (Seiler and
Spielmann, 2011). In agreement with the protocol, we routinely
observed cell contractions with frequency 1–2 Hz after 12 days
of cell differentiation (Supplementary Video 1). Surprisingly,
we failed to detect UCP3 at any stage of mESC differentiation
(Figure 2A), although mESC-derived CM showed the expression
of α-actin (Figure 2B).
FIGURE 2 | Protein expression during cardiomyocytes differentiation. (A–E) Representative WBs and quantification analysis of UCP3 (A), α-actin (B), mitochondrial
markers – CI, CII, CV, VDAC (C), UCP2 (D) and cardiac markers Troponin C, Troponin I, GATA4, SERCA2 and muscle marker SERCA1 (E) during cardiomyocytes
differentiation. Antibody against OCT3/4 was used as a stem cell marker; Antibody against GAPDH was used as a loading control. Recombinant mouse UCP3
(mUCP3, 5 ng) was used as a positive control. 20 µg of total protein from cell lysate were loaded per lane. Cells were collected at different time points from 3 to 6
independent differentiation experiments. The relative protein amounts were calculated as a ratio between the line intensity of sample to the intensity mean of all
values loaded on the membrane. Data are presented as mean values ± SEM, ∗∗∗p < 0.001.
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To control whether the abundance of other mitochondrial
proteins was impaired at any point of mESC differentiation, we
traced the expression behavior of VDAC, CI, CII, CV, and UCP2.
Figure 2C reveals that stem cells displayed a high expression
of RC proteins indicating their high metabolic activity. The
expression was declined in EB (d5) and increased again after
day 7 in culture, basically mirroring the expression pattern of
RC proteins during murine heart development (Figures 1D,E).
UCP2 was abundant not only in stem cells, but also at the
late stages of differentiation (Figure 2D), implying that the
mESC, differentiated in this way, still have features of stem cells
despite the absence of Oct3/4. To support this hypothesis, we
tested the expression of the specific CM markers. Figure 2E
demonstrates that TnC, Troponin I, GATA4 and SERCA2 were
not present during the whole differentiation time. The absence of
Ca2+-ATPase type 1 (SERCA1) specifically expressed in muscles
FIGURE 3 | Comparison of mitochondria shape and cristae during mESC differentiation to cardiomyocytes and heart development. (A) Representative electron
microscopy pictures of mouse embryonic stem cells (mESC, left) embryo bodies (EB, middle) and mESC-derived CM at day 19 (d19, right). Detailed images of
mitochondria at magnification 30000X are shown. Scale bar – 500 nm. (B) Representative TMRE fluorescence images of mESC and mESC-derived CM at d14. Scale
bar - 10 µm. Pictures were taken from 2 to 3 independent differentiation experiments. (C) Quantification of cristae amount per mitochondria. Data are presented as
mean values ± SEM, ∗∗∗p < 0.001. (D) Representative electron microscopy pictures of mitochondria heart tissue (magnification 12000× top, and 30000× bottom)
in E18, newborn day 1 (P1), day 7 (P7) and adult day 30 (P30) mice. M, mitochondria; N, nucleus; L, lipid droplets; F, cardiac myofibrils; arrow - LD/Mitochondria
contact; ∗ - glycogen. Embryos (E18) or postnatal (P1-30) heart tissue from at least two different animals were analyzed per group. Scale bar – 500 nm.
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(Figure 2E), allowed us to exclude the differentiation of stem cells
in myoblasts.
Appearance of Lipid Drops Coincides
With High Expression of UCP3
Analysis of the expression pattern of cardiomyocyte markers
presented in Figure 2E led us to the hypothesis that the cell’s
mitochondria in the model of stem cell differentiation are still
immature, despite the existing electrical activity and presence
of α-actin. To evaluate this, we visualized the mitochondrial
shape and number of cristae at three time points during
stem cell differentiation using electron microscopy. Figure 3A
demonstrates that mESCs have mostly round mitochondria with
a low cristae density. At the start of differentiation, the size of
mitochondria in EB decreased and the density of cristae remained
low (Figures 3A,C). At day 14 mitochondria exhibited more
variability showing round and elongated shapes (Figure 3B),
probably indicating the higher fusion/fission rate (Chen and
Chan, 2005; Berman et al., 2008; Benard and Karbowski, 2009),
but still had a lower number of cristae, when compared to CM
from adult heart (Figures 3C,D).
The electron microscopy of CM from postnatal mice
(P7 and P30) revealed the appearance of big lipid droplets
(Figure 3D; L), which were absent in differentiated stem cells
(Figure 3A) and embryonic cells, having large stores of glycogen
instead (Figure 3D). LDs are known as storage organelles for
triglycerides, which are used by mitochondria in the β-oxidation
pathway (FAO) (Farese and Walther, 2009; Schulze et al., 2016;
Schuldiner and Bohnert, 2017). We detected direct contacts that
several mitochondria of mature CM built to the LD surface
(Figure 3D, arrows). This type of contact between mitochondria
and lipid droplets was previously described for animals under
high-fat diets or diabetes type 2 (Aon et al., 2014).
Expression of UCP2 and UCP3 Depends
on Type of Cell Metabolism
It is well-known that adult CM predominantly have a FAO
type of metabolism (Lopaschuk and Jaswal, 2010). To support
the idea that immature mitochondria in mESC-derived CM
have a different metabolism than adult CM, we performed
measurements of the OCR and ECAR in mESC-derived CM at
day 14 using Seahorse extracellular flux analyzer (Figure 4A).
Analysis of the OCR and ECAR in media containing the
same amounts of glucose and amino acids as the standard
“maintenance media” revealed a glycolytic type of energy
metabolism similar to that of the undifferentiated mESC with a
slight shift to an oxidative metabolism (Figure 4A). The more
quiescent metabolism of mESC-derived CM at d14 reflects less
energetic requirements than in adult CM, and shows that they are
not fully active, in comparison to the highly proliferative mESC.
To establish another link between UCP3 expression and
FAO in developing heart and CM under differentiation we
evaluated mRNA transcripts of several proteins which were
demonstrated to be important at different steps of the β-oxidation
pathway such as transcriptional co-activation and mitochondrial
biogenesis (PGC1a), cellular FA transport (FATP6/SLC27A6),
FIGURE 4 | Characterization of cell metabolism during stem cell differentiation
into cardiomyocytes using the extracellular flux analyzer. (A) Determination of
the energetic profile of mESC (open circles) and mESC-derived CM at d14
(gray filled circles) using extracellular flux analyzer under standard media
conditions from three independent experiments. (B,C). Quantitative RT-PCR
mRNA transcript analysis of β-oxidation markers (PGC1a, FATP6, CPT1B, and
ACADVL) at different time points during mouse heart development (B) and
mESC differentiation into cardiomyocytes (C). Results are presented relative
to mRNA amounts of the housekeeping gene GAPDH. Each data point
represents the mean value ± SEM of at least n = 3 animals per age.
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mitochondrial FA uptake (CPT1B) and FA enzymatic cleavage
(ACADVL) (Huss and Kelly, 2004; Black et al., 2009; Lopaschuk
and Jaswal, 2010; Rowe et al., 2010). To increase marker
specificity for heart cardiomyocyte-abundant isomers were
chosen. We observed a rise of PGC-1α expression from
embryonic to postnatal stage (Figure 4B). This confirms a
known sharp PGC-1α expression increase directly after birth
which was shown to coincide with a perinatal shift from glucose
metabolism to FAO (Huss and Kelly, 2004). mESC-derived CMs
showed only slight PGC-1α increase during their differentiation
(Figure 4C), which not reached the same expression level as in
young hearts or even embryonic heart (Figure 4B). Similarly,
the mitochondria-associated CPT1B and ACADVL showed a
rise in their transcript levels during heart development, but
a constantly low expression level during CM differentiation.
Interestingly, the heart specific FATP6, which is responsible for
the cellular FA uptake showed the same expression pattern during
heart development and cardiomyocyte differentiation. PGC1 and
FATP6 gene expression was below the detection limit in stem cells
and in E18 hearts.
DISCUSSION
By using mESC-derived CM in this study, we have revealed that
the appearance of UCP3 in heart cannot be attributed to the
establishment of electrical/contractile activity in CM, which is
the main criterion for the successful mESC differentiation in
all protocols (Seiler and Spielmann, 2011; Niehoff et al., 2016).
UCP3′s presence is rather an indicator of CM’ maturity, which
includes (i) the presence of specific CM markers – SERCA2, TnC
and GATA4 (Figure 1C), (ii) an increase of cristae density in
mitochondria (Figure 3C), (iii) the appearance of lipid droplets
(LD) and the establishment of multiple contacts between LD
and mitochondria (Figure 3D, arrows), and, the most important,
(iv) a switch to FAO as a main type of cell metabolism
(Figure 4 and (Lopaschuk and Jaswal, 2010; Mdaki et al., 2016)).
These findings are in agreement with the time course of UCP3
expression during heart development (Figure 1A) and with
several studies implying the correlation between UCP3 and
metabolism (Hilse et al., 2016). It was shown at gene expression
level that UCP3 was downregulated in fetal and failing human
heart (Razeghi et al., 2001) and was increased by ligand activation
of PPARα (Young et al., 2001), known as a major regulator of
genes involved in the lipid metabolism in liver, heart, and muscle
(Warren et al., 2017).
Whereas UCP3 revealed a strong time correlation with
proteins indicating the differentiation stage of cells and the
maturity of the metabolism, we observe no time coincidence
between UCP3 and RC proteins abundance (RCP, Figure 1D),
implying a weak connection between the function of these
proteins. Moreover, the decrease in UCP3 abundance found in
mitochondria of aging heart is in line with the impairment in
FAO and a shift toward carbohydrate metabolism (Lesnefsky
et al., 2016). Therefore, UCP3 expression can reflect the
FAO capacity and indicate metabolic impairments in adult
heart.
UCP3 is supposed to be localized on the inner boundary of
the mitochondrial membrane, analogous to other uncoupling
proteins (Klotzsch et al., 2015), and was shown to transport
protons with a similar turnover rate as UCP1 and UCP2
(Urbankova et al., 2003; Beck et al., 2007; Macher et al., 2018).
However, other transported molecules, such as FA (Schrauwen
et al., 2001), fatty acid peroxides (Goglia and Skulachev, 2003;
Lombardi et al., 2010; Senese et al., 2011) and pyruvate (Criscuolo
et al., 2006) instead or alongside with protons, were also
proposed. This additional transport pathway is in line with
the putative involvement of UCP3 in (fatty acid) metabolism,
which has been described for muscles (Clapham et al., 2000;
Himms-Hagen and Harper, 2001) and for adult CM in this work.
FIGURE 5 | Correlation between metabolism type, morphology of mitochondria and UCP2/UCP3 protein content in cardiomyocytes at different time point of heart
development. LD, lipid droplets, E18-embryonic day 18.
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Our present results which reveal the tight correlation between
increase in UCP3 amount, expression of mitochondrial FAO
maturation markers and establishment of multiple connections
between mitochondria and LD may support the hypothesis that
UCP3 facilitates FAO metabolism by transporting FAs. Although
the transport of FA outside mitochondria as a function of UCP3
was already proposed by several groups (Himms-Hagen and
Harper, 2001; Schrauwen et al., 2006), the tight connection
between huge lipid droplets and mitochondria at the peak of
UCP3 expression let us speculate that UCP3 may transport FAs
inside mitochondria.
In contrast to the reports of several research groups (Cabrera
et al., 2012; Perrino et al., 2013), we have not found UCP2 in
adult murine heart under physiological conditions. However,
we detected UCP2 in mESC and in embryonal/neonatal heart
(Figure 1B) alongside with low cristae density and increased
glycogen stores (Figure 3D) as typical features of tissues with
glycolytic type of metabolism (Lopaschuk et al., 1991). It is
known that mammalian CM can avidly proliferate during fetal
and neonatal development (Xin et al., 2013; Foglia and Poss,
2016). The rapid ventricular remodeling that occurs over the
few days after birth can explain the additional UCP2 expression
peak, which we detected between P1 and P7. We also revealed
UCP2 in mESC-derived CM alongside with glycolytic type of
metabolism observed in extracellular flux analysis experiments
(Figure 4). These results additionally support the idea that
CM’s contractile activity and the expression of the alpha-actin
are not sufficient to regard these cells as mature CM. It was
reported earlier that UCP2 modulates myocardial excitation-
contraction coupling (Turner et al., 2010) and/or attenuates
ROS generation (Teshima et al., 2003) if ectopically expressed in
neonatal CM.
Previously, we have observed that another uncoupling protein,
UCP4, can be detected in brain and in neurons derived from
the same mESC, but only simultaneously with the appearance of
neuronal cell markers which indicated the switch from glycolytic
metabolism to oxidative phosphorylation (Smorodchenko et al.,
2009, 2011; Rupprecht et al., 2014). Notably, the neuroblastoma
cell line, usually used as a model for primary neurons, expresses
UCP2 instead of UCP4 (Rupprecht et al., 2014) coinciding
with the expression of cancer cell markers and glycolytic cell
metabolism. The expression pattern of uncoupling proteins,
therefore, strengthens the new concept about their involvement
in metabolism in stem cells and immature CM on the one side
(UCP2), and adult CM on the other side (UCP3).
CONCLUSION
We have demonstrated a clear overlap between a cellular
bioenergetics profile, lipid droplet accumulation, expression of
specific CM maturity and FAO markers and UCP3 protein
content in heart tissue at different time point of the development
(Figure 5). Understanding that the expression patterns of UCP3
and UCP2 in heart are different and reflect the metabolic type
and cell differentiation degree is an important step for uncovering
their exact functions in CM metabolism.
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